Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma

doi:10.5306/wjco.v16.i3.101098

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (337)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

121

Figures (1-1)

Tables (1-1)

Sum=197

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=122

Publishing Process of This Article

Item

Count

Browse

Download

Sum=6

Mar 24, 2025 (publication date) through Feb 3, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Mar 24, 2025; 16(3): 101098
Published online Mar 24, 2025. doi: 10.5306/wjco.v16.i3.101098

Open in New Tab Full Size Figure Download Figure

Figure 1 Scheme for the human β-defensin-1-loaded immunoliposome design. EGFR: Epidermal growth factor receptor; HBD-1: Human β-defensin-1.

Citation: Huang Y, Wang XY, Huang JY, Huang ZW. Incorporation of human β-defensin-1 into immunoliposomes to facilitate targeted autophagy therapy of colon carcinoma. World J Clin Oncol 2025; 16(3): 101098
URL: https://www.wjgnet.com/2218-4333/full/v16/i3/101098.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i3.101098